The Minneapolis/St. Paul Business Journal has named its Women in Business honorees, which include Cheryl Beal Anderson, vice president of global regulatory affairs at Upsher-Smith Labs.
Spiriva Handihaler had a market value of $1.5 billion for the 12 months ended May 2021, although actual generic market values are expected to be lower.
Semglee is both biosimilar to and interchangeable with Lantus, and is the first interchangeable biosimilar approved by the Food and Drug Administration.